After joining the University of Michigan faculty in 1994, Mauro Moscucci, M.D., M.B.A., was asked to explain why the mortality rate for patients who underwent angioplasty at the university’s hospital was much higher than that of a regional center. He assumed the sickest patients were being transferred to the university, but having no data to support that, he began collecting it, improving coronary care for everyone.
Read more on the Miller School Web site »
The Miller School’s Interdisciplinary Stem Cell Institute (ISCI) and the Diabetes Research Institute are on the world stage of stem cell research this week, uniting with the Genetics Policy Institute to co-sponsor the world’s largest and most comprehensive interdisciplinary stem cell conference, in Florida for the first time.
Read more on the Miller School Web site »
In a study that could help advance the field of regenerative medicine for years to come, the Interdisciplinary Stem Cell Institute at the Miller School has found that mesenchymal stem cells, whether from patients or donors, can treat people whose hearts were previously damaged and scarred after a heart attack.
Read more on the Miller School Web site »
